Back to MW MARSHALL WACE, LLP

ZNTLZNTL
Showing 6 of 11 quarters

Position history for MWMARSHALL WACE, LLP's holdings in ZENTALIS PHARMACEUTICALS INC

Yes. Marshall Wace holds 591,473 shares of ZNTL (Zentalis Pharmaceuticals), worth $2.9M, as of its Q2 2026 13F filing. It increased the position by 198,830 shares (+50.6%) from Q1 2026. Marshall Wace has held ZNTL since Q4 2025, across 3 quarterly 13F filings.

Current Value

$2.9M

Current Shares

591,473

Total Value Change

+$2.5M

Total Shares Change

+502,461

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
591,473
+50.6%
$2.9M0.0%$4.85
37
2026-Q1
Increased
392,643
+58.5%
$918,7850.0%$2.38
36
2025-Q4
New
247,788
-
$334,5130.0%$1.33
33
2025-Q1
Exited
0
-100.0%
$00.0%$1.81
0
2024-Q4
Unchanged
89,012
0.0%
$269,7060.0%$2.92
0
2024-Q3
Unchanged
89,012
0.0%
$327,5640.0%$3.75
0

Other major holders of ZNTL: FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used